[Biochemical aspects of vascular pharmacology (literature review)].
D000262:Adenylyl Cyclases / Q000378:metabolism; D000628:Aminophylline / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002395:Catecholamines / Q000494:pharmacology; D000242:Cyclic AMP / Q000096:biosynthesis; D005730:Ganglionic Blockers / Q000494:pharmacology*; D005958:Glucosephosphates / Q000378:metabolism; D006145:Guanethidine / Q000494:pharmacology; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology; D009129:Muscle Tonus / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D009573:Nitrites / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D011817:Rabbits; D012110:Reserpine / Q000494:pharmacology; D014655:Vascular Resistance / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*; D014667:Vasopressins / Q000494:pharmacology
D000925:Anticoagulants; D000959:Antihypertensive Agents; D002395:Catecholamines; D005730:Ganglionic Blockers; D005958:Glucosephosphates; D009573:Nitrites; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D014667:Vasopressins; D000804:Angiotensin II; D000628:Aminophylline; D012110:Reserpine; D010208:Papaverine; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D007545:Isoproterenol; D006145:Guanethidine
Biokhimicheskie aspekty sosudistoĭ farmakologii (obzor literatury.